314 related articles for article (PubMed ID: 25977149)
1. Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation.
Lee SY; Jo JS; Kim HJ; Kim CH; Kim YJ; Kim HR
J Surg Oncol; 2015 Jun; 111(8):1054-8. PubMed ID: 25977149
[TBL] [Abstract][Full Text] [Related]
2. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
[No Abstract] [Full Text] [Related]
3. Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.
Kang J; Hur H; Min BS; Lee KY; Kim NK
Ann Surg Oncol; 2012 Jan; 19(1):154-5. PubMed ID: 21822556
[TBL] [Abstract][Full Text] [Related]
4. [Effects of tumor distance from anal verge and types of operations on survival outcomes for low rectal cancer after neoadjuvant chemoradiotherapy].
Xiao Y; Wu B; Qiu H; Xiong G; Lin G; Zhong G; Hu K; Pan W
Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(22):1705-9. PubMed ID: 25151899
[TBL] [Abstract][Full Text] [Related]
5. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
[TBL] [Abstract][Full Text] [Related]
6. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
Weiser MR; Quah HM; Shia J; Guillem JG; Paty PB; Temple LK; Goodman KA; Minsky BD; Wong WD
Ann Surg; 2009 Feb; 249(2):236-42. PubMed ID: 19212176
[TBL] [Abstract][Full Text] [Related]
7. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
[TBL] [Abstract][Full Text] [Related]
8. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
Lee SY; Kim CH; Kim YJ; Kim HR
J Surg Oncol; 2018 Mar; 117(3):514-522. PubMed ID: 29094377
[TBL] [Abstract][Full Text] [Related]
13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
14. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.
Lee SD; Kim TH; Kim DY; Baek JY; Kim SY; Chang HJ; Park SC; Park JW; Oh JH; Jung KH
Eur J Surg Oncol; 2012 Jun; 38(6):478-83. PubMed ID: 22465588
[TBL] [Abstract][Full Text] [Related]
16. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
17. Low rectal cancer: classification and standardization of surgery.
Rullier E; Denost Q; Vendrely V; Rullier A; Laurent C
Dis Colon Rectum; 2013 May; 56(5):560-7. PubMed ID: 23575394
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes of intersphincteric resection without preoperative chemoradiotherapy for very low rectal cancer.
Akagi Y; Shirouzu K; Ogata Y; Kinugasa T
Surg Oncol; 2013 Jun; 22(2):144-9. PubMed ID: 23591063
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]